Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
about
Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virusA Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsChimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile VirusMonoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse SeraInduction of Epitope-Specific Neutralizing Antibodies against West Nile VirusIdentification of Mutated Cyclization Sequences That Permit Efficient Replication of West Nile Virus Genomes: Use in Safer Propagation of a Novel Vaccine CandidateEvaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysA recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsWest Nile virus meningoencephalitisEvaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adultsWest Nile virus vaccines.ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.Current trends in West Nile virus vaccine development.Recent advancement in flavivirus vaccine development.West Nile virus: a growing concern?Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virusA review of vaccine approaches for West Nile virus.The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.Flavivirus encephalitis: pathological aspects of mouse and other animal models.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.West Nile virus
P2860
Q27304916-BB007B9C-CFD7-467E-BC73-722245040C5EQ27321020-32D8217B-F5D4-4A8F-9B87-DD607F419901Q27469831-6529F487-C650-4C5B-8E63-1DAC7368F289Q27478079-7D4E578B-B1F3-4CE4-BD8D-306F97319F23Q27484980-9C64F0DD-9B1A-4D5E-B346-AE818B806057Q27486407-A1E9496A-C6AD-432C-9CC1-0B0A7029A4F1Q27487013-35DAF776-3F42-4755-95F5-C6F5BF04AFB7Q27487992-C7B0038B-9DA7-480B-AD47-056A8F3C78CBQ28260103-E13BE226-9938-4C44-B55C-A57FF066172CQ33880730-E1A51098-17B6-4497-9199-94D7B3D79CDDQ33909344-6E0AB97F-0081-494D-BB6B-1548FFA54E78Q33911897-16AC55F7-1729-4F76-B580-1B54E0863786Q34154300-FDAA0E61-9044-4AA4-86F4-FE092EF13A96Q34335105-51E6C8EC-5F81-4A1F-8CBF-D2AACE28B9B1Q34362322-474B0FEE-DB5F-42EA-A112-286410856B13Q34788758-193B9EC2-942F-4290-81DA-E3CF218CA23EQ35728621-187435C0-D327-4943-8AF5-4E8D8FFB88BEQ35746093-916B5613-3606-444A-8F5A-150413EEDFD5Q36136167-210221A8-0E78-4F8D-87DE-83C997491A0EQ37236968-0F850D15-CD70-428E-950C-38DEE9AEAB09Q37324444-5A56C9BC-94A1-4FB5-989F-8390893E94C7Q37765386-C2876D06-7F64-4A36-925F-B7808D49C385Q37842337-51AC8E1A-63CE-412F-A3AB-B029C831C0C0Q38866173-938E47F1-2410-494E-ACC1-3BC8A953BEC7Q40073429-D9AFE33A-87E2-46F5-BF68-0BADC9503205Q56932479-60CAF4F7-28DA-4225-A3B7-41FE3224644F
P2860
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecularly engineered live-at ...... monkeys from West Nile virus.
@en
type
label
Molecularly engineered live-at ...... monkeys from West Nile virus.
@en
prefLabel
Molecularly engineered live-at ...... monkeys from West Nile virus.
@en
P2093
P921
P1433
P1476
Molecularly engineered live-at ...... monkeys from West Nile virus.
@en
P2093
Alexander G Pletnev
Brian R Murphy
Jim Speicher
Marisa St Claire
Randy Elkins
Robert M Chanock
P304
P356
10.1016/S0042-6822(03)00450-1
P407
P577
2003-09-01T00:00:00Z